Literature DB >> 23584902

Echocardiography for the detection of portopulmonary hypertension in liver transplant candidates: an analysis of cutoff values.

Sarah Raevens1, Isabelle Colle, Koen Reyntjens, Anja Geerts, Frederik Berrevoet, Xavier Rogiers, Roberto I Troisi, Hans Van Vlierberghe, Michel De Pauw.   

Abstract

Portopulmonary hypertension (POPH), a complication of chronic liver disease, may be a contraindication to liver transplantation (LT) because of the elevated risk of peritransplant and posttransplant morbidity and mortality. Because POPH is frequently asymptomatic, screening with echocardiography is recommended. The only reliable technique, however, for diagnosing POPH is right heart catheterization (RHC). The aims of this study were to evaluate the current estimated systolic pulmonary artery pressure (sPAP) cutoff value of 30 mm Hg and to determine a better cutoff value. One hundred fifty-two patients underwent pretransplant echocardiography between January 2005 and December 2010. These echocardiographic results were compared with pulmonary artery pressures measured during the pretransplant workup or at the beginning of the transplantation procedure (both by catheterization). With a cutoff value of 30 mm Hg, 74 of the 152 patients met the criteria for POPH on echocardiography, although the diagnosis was confirmed in only 7 patients during catheterization; this resulted in a specificity of 54%. It would have been more accurate to use a cutoff value of 38 mm Hg, which had a maximal specificity of 82% and, at the same time, guaranteed a sensitivity and negative predictive value of 100%. With the incorporation of the presence or absence of right ventricular dilatation, the specificity even increased to 93% for this new cutoff value. In conclusion, the prevalence of POPH was 4.6% among LT candidates in this study. We can recommend that LT candidates with an sPAP > 38 mm Hg should be referred for RHC. With the cutoff value increased from 30 to 38 mm Hg, the number of patients undergoing invasive RHC during their evaluation could be safely reduced.
Copyright © 2013 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2013        PMID: 23584902     DOI: 10.1002/lt.23649

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  13 in total

Review 1.  The Art and Science of Diagnosing and Treating Lung and Heart Disease Secondary to Liver Disease.

Authors:  David S Goldberg; Michael B Fallon
Journal:  Clin Gastroenterol Hepatol       Date:  2015-04-28       Impact factor: 11.382

Review 2.  Portopulmonary hypertension in liver transplant candidates.

Authors:  Serife Savas Bozbas; Huseyin Bozbas
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

Review 3.  Early detection of pulmonary arterial hypertension.

Authors:  Edmund M T Lau; Marc Humbert; David S Celermajer
Journal:  Nat Rev Cardiol       Date:  2014-11-25       Impact factor: 32.419

Review 4.  Ultrasonography in the diagnosis of complications in patients with portal hypertension.

Authors:  Hisashi Hidaka; Haruki Uojima
Journal:  J Med Ultrason (2001)       Date:  2021-11-17       Impact factor: 1.878

Review 5.  Doppler trans-thoracic echocardiography for detection of pulmonary hypertension in adults.

Authors:  Yasushi Tsujimoto; Junji Kumasawa; Sayaka Shimizu; Yoshio Nakano; Yuki Kataoka; Hiraku Tsujimoto; Michihiko Kono; Shinji Okabayashi; Haruki Imura; Takahiro Mizuta
Journal:  Cochrane Database Syst Rev       Date:  2022-05-09

6.  The early outcomes of candidates with portopulmonary hypertension after liver transplantation.

Authors:  Bingsong Huang; Yi Shi; Jun Liu; Paul M Schroder; Suxiong Deng; Maogen Chen; Jun Li; Yi Ma; Ronghai Deng
Journal:  BMC Gastroenterol       Date:  2018-06-07       Impact factor: 3.067

7.  Correlation between Echocardiographic Pulmonary Artery Pressure Estimates and Right Heart Catheterization Measurement in Liver Transplant Candidates.

Authors:  Fuad Habash; Pooja Gurram; Ahmed Almomani; Andres Duarte; Abdul Hakeem; Srikanth Vallurupalli; Sabha Bhatti
Journal:  J Cardiovasc Imaging       Date:  2018-06-22

8.  Diagnostic accuracy of transthoracic echocardiography for pulmonary hypertension: a systematic review and meta-analysis.

Authors:  Jin-Rong Ni; Pei-Jing Yan; Shi-Dong Liu; Yuan Hu; Ke-Hu Yang; Bing Song; Jun-Qiang Lei
Journal:  BMJ Open       Date:  2019-12-22       Impact factor: 2.692

9.  Role of echocardiography in screening for portopulmonary hypertension in liver transplant candidates: a meta-analysis.

Authors:  Xin Yin; Yueming Shao; Yu Zhang; Hui Gao; Tingting Qin; Xiaoyu Wen; Chen Yang
Journal:  PeerJ       Date:  2020-05-27       Impact factor: 2.984

10.  Evaluation of Predisposing Metabolic Risk Factors for Portopulmonary Hypertension in Patients with NASH Cirrhosis.

Authors:  Fatih Türker; Tolga Sahın; Alihan Oral; Erdem Koçak; Betül Çavuşoğlu Türker; Adil Niğdelioğlu; Hayriye Esra Ataoğlu
Journal:  Int J Gen Med       Date:  2022-01-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.